Telmisartan in Combination with Different Drugs for Mild to Moderate Essential Hypertension:Cost-Effectiveness Analysis / 中国药房

OBJECTIVE:To evaluate the cost-effectiveness of telmisartan in combination with different drugs in the trea-tment of mild to moderate essential hypertension.METHODS:A total of 60 patients were enrolled and randomized to Group A(telmisartan+felodipine),Group B(telmisartan+enalapril),or Group C(telmisartan+indapamide).A cost-effectiveness analysis of the three therapeutic schemes was conducted after 8-wk treatment.RESULTS:The effective rates of three Groups were 90%,85% and 95%,respectively;the total costs of three groups were 422.80,409.50 and 348.88 yuan,respectively,with Group C showing significant difference as compared with the other two groups(Group B and Group C)(P